Literature DB >> 29239035

Heritable forms of primary hyperparathyroidism: a current perspective.

Ronald A DeLellis1, Shamlal Mangray1.   

Abstract

Primary hyperparathyroidism (PHPT) is one of the most common of all endocrine disorders encountered by the practising histopathologist. The vast majority of lesions are sporadic in nature, approximately 85% of which are parathyroid adenomas, while hyperplasia and carcinoma account for 10-15% and fewer than 1%, of cases, respectively. Heritable forms of PHPT are much less common and present challenges both to clinicians and pathologists, particularly when they are the presenting feature of an endocrine syndrome. In such instances, pathologists play a key role in alerting physicians to the possibility of an underlying heritable endocrine syndrome and the potential for extra-endocrine manifestations. Therefore, a working knowledge of these disorders is essential for providing guidance to treating physicians. The aim of this update is to review the clinicopathological features, genetic bases and current management for patients with PHPT associated with multiple endocrine neoplasia (MEN) types 1, 2A and 4 and hyperparathyroidism-jaw tumour (HPT-JT) syndrome in the context of the 2017 World Health Organization (WHO) Classification of Tumours of the Endocrine Organs. Additionally, familial isolated hyperparathyroidism, familial hypocalciuric hypercalcaemia and neonatal severe hyperparathyroidism are discussed.
© 2017 John Wiley & Sons Ltd.

Entities:  

Keywords:  familial; hyperparathyroidism; hypocalciuric hypercalcaemia; jaw tumour syndrome; multiple endocrine neoplasia

Mesh:

Year:  2018        PMID: 29239035     DOI: 10.1111/his.13306

Source DB:  PubMed          Journal:  Histopathology        ISSN: 0309-0167            Impact factor:   5.087


  5 in total

1.  GIANT MEDIASTINAL PARATHYROID ADENOMAS AND MULTIPLE ENDOCRINE NEOPLASIA TYPE 1: A DIAGNOSTIC CONUNDRUM.

Authors:  A Gautam; A Rastogi; S K Bhadada
Journal:  Acta Endocrinol (Buchar)       Date:  2022 Jan-Mar       Impact factor: 1.104

2.  Outcome of Clinical Genetic Testing in Patients with Features Suggestive for Hereditary Predisposition to PTH-Mediated Hypercalcemia.

Authors:  Shafaq Khairi; Jenae Osborne; Michelle F Jacobs; Gregory T Clines; Barbra S Miller; David T Hughes; Tobias Else
Journal:  Horm Cancer       Date:  2020-08-05       Impact factor: 3.869

3.  HIGH RISK OF PARATHYROID CARCINOMA AND GENETIC SCREENING IN THE FIRST DIAGNOSED ROMANIAN FAMILY WITH HYPERPARATHYROIDISM-JAW TUMOR SYNDROME AND A GERMLINE MUTATION OF THE CDC73 GENE.

Authors:  D Grigorie; A Sucaliuc; S Ciuffi; F Franceschelli; F Marini; D Ioachim; D Terzea; M L L Brandi
Journal:  Acta Endocrinol (Buchar)       Date:  2019 Jul-Sep       Impact factor: 0.877

4.  Parathyroid carcinoma with sarcomatoid differentiation: a case report and literature review.

Authors:  Liang Hu; Xiaojun Xie
Journal:  Diagn Pathol       Date:  2020-12-14       Impact factor: 2.644

5.  Hypercalcemic crisis caused by primary hyperparathyroidism in a 11-year-old boy: a rare case report and review of the literature.

Authors:  Shigeki Hayashi; Takaaki Oba; Kanami Ichikawa; Chizuko Nakamura; Yosuke Hara; Toshiharu Kanai; Yoshinori Sato; Takeshi Uehara; Ken-Ichi Ito
Journal:  Gland Surg       Date:  2022-07
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.